Sign inJoin waitlistJoin the waitlist

MW

Meir Wetzler

Credentials: · ·

History

Medical Oncology
Internal Medicine

Research

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
Blood · 2015 · 842 citations
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
Nature · 2015 · 728 citations
Therapeutic advances in acute myeloid leukemia
Review · Journal of Clinical Oncology · 2011 · 653 citations

Eunice Wang
59 papers
Maria Baer
50 papers
MT
Moshe Talpaz
33 papers
Razelle Kurzrock
28 papers
CB
Clara Bloomfield
25 papers
Bayard Powell
23 papers
Elizabeth Griffiths
23 papers
Hagop Kantarjian
23 papers
Richard Larson
22 papers
MB
Maurice Barcos
20 papers
Guido Marcucci
19 papers
JK
Jonathan Kolitz
19 papers

Grants

Arsenic Trioxide Down-Regulates STAT3 Activity in AML
National Cancer Institute · R21
Contact PI · $776.7K · Roswell Park Cancer Institute Corp
2003–2006

Clinical trials

Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy
Principal investigator · Terminated · Phase 2
Roswell Park Cancer Institute
2011–2015
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 2
Roswell Park Cancer Institute
2008–2013
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens
Principal investigator · Terminated · Phase 2
BioCryst Pharmaceuticals
2006–2007
Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
Principal investigator · Completed · Phase 1, Phase 2
Novartis Pharmaceuticals
2004–2006